TMPO and posterior cortical atrophy: Knockdown of TMPO-AS1L could inhibit PCa cells BM in vivo and induced a pro-metastatic state in vitro, indicating that targeting TMPO-AS1L might represent a novel and effective anti-BM treatment regimen in PCa.